FRAZIER LIFESCIENCES ACQUISITION CORPORATION

Insiders Frazier Lifesciences Acquisition Corporation

Equities

NAMS

NL00150012L7

End-of-day quote Nasdaq Other stock markets 23:00:00 22/05/2024 BST			5-day change	1st Jan Change
19.1 ^EUR	-2.45%		-3.73%	+70.99%

05-16	Transcript : NewAmsterdam Pharma Company N.V. - Special Call
05-15	TD Cowen Starts NewAmsterdam Pharma With Buy Rating	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NewAmsterdam Pharma Names Juliette Audet Chief Business Officer	04-01	MT
Newamsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer	04-01	CI
Newamsterdam Pharma Insider Sold Shares Worth $4,095,234, According to a Recent SEC Filing	03-27	MT
NewAmsterdam Pharma Company N.V. Announces Board Changes	01-08	CI
NewAmsterdam Pharma Appoints Ian Somaiya as Chief Financial Officer	23/10/23	MT
NewAmsterdam Pharma Announces Appointment of Ian Somaiya as Chief Financial Officer	23/10/23	CI
NewAmsterdam Pharma Appoints William Jones as First Chief Commercial Officer	14/08/23	MT
NewAmsterdam Pharma Company N.V. Appoints William ?BJ" Jones as Chief Commercial Officer	14/08/23	CI
NewAmsterdam Pharma Company Appoints Janneke van der Kamp to its Board of Directors	03/04/23	CI
NewAmsterdam Pharma Company N.V. Appoints John W. Smither as Independent Director	06/02/23	CI
NewAmsterdam Pharma Names David Topper CFO	19/12/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer